Literature DB >> 10843288

Inherited medullary microcarcinoma of the thyroid: a study of 11 cases.

J E Krueger1, A Maitra, J Albores-Saavedra.   

Abstract

The authors report 11 patients with genetically determined medullary microcarcinomas. Nine patients were either children or adolescents and two patients were young adults. The youngest patient was 7 years old and the oldest was 34 years of age (mean age, 15.4 yrs). The preoperative diagnosis was based on family history and elevated serum calcitonin levels. In addition, six patients had RET protooncogene mutations in exons 10, 11, and 16. Two patients who had the RET protooncogene mutations did not have serum calcitonin measurements. Nine patients had bilateral medullary microcarcinomas (<1.0 cm), whereas the two patients with unilateral tumors demonstrated multifocal disease. The principle microscopic differences between these genetically determined medullary microcarcinomas and larger sporadic (>1 cm) medullary carcinomas were the low incidence of stromal desmoplasia and amyloid deposition, the high incidence of C-cell hyperplasia, and the low incidence of lymph node metastases. Only one patient, a 34-year-old man, presented with lymph node metastases. All patients remain disease free 11 to 70 months after diagnosis. This small series of thyroid microcarcinomas illustrates the impact molecular diagnostics is having on the management and prognosis of genetically determined medullary carcinoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843288     DOI: 10.1097/00000478-200006000-00011

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  9 in total

Review 1.  C-cell hyperplasia and medullary thyroid microcarcinoma.

Authors:  J A Albores-Saavedra; J E Krueger
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

2.  An immunohistochemical survey of nine cases of medullary carcinoma of thyroid including reactivity for Cox-1 and Cox-2 enzymes.

Authors:  C David Bell; Sergio Vidal; Kalman Kovacs; Eva Horvath; Fabio Rotondo
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 3.  The pathology of preclinical medullary thyroid carcinoma.

Authors:  Michael Ashworth
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

4.  Clinicopathological Significance and Prognosis of Medullary Thyroid Microcarcinoma: A Meta-analysis.

Authors:  Jin Hwa Kim; Jung-Soo Pyo; Won Jin Cho
Journal:  World J Surg       Date:  2017-10       Impact factor: 3.352

Review 5.  Is Hashimoto's thyroiditis a risk factor for medullary thyroid carcinoma? Our experience and a literature review.

Authors:  Ayman A Zayed; Moaath K Mustafa Ali; Omar I Jaber; Moh'd J Suleiman; Ashraf A Ashhab; Wajdi Mohammed Al Shweiat; Munther Suliaman Momani; Maha Shomaf; Salah Mohammed AbuRuz
Journal:  Endocrine       Date:  2014-07-24       Impact factor: 3.633

6.  Tenascin C in medullary thyroid microcarcinoma and C-cell hyperplasia.

Authors:  Oskar Koperek; Astrid Prinz; Christian Scheuba; Bruno Niederle; Klaus Kaserer
Journal:  Virchows Arch       Date:  2009-05-30       Impact factor: 4.064

7.  Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement.

Authors:  Sébastien Aubert; Amandine Berdelou; Viviane Gnemmi; Hélène Behal; Robert Caiazzo; Michèle D'herbomez; Pascal Pigny; Jean Louis Wemeau; Bruno Carnaille; Florence Renaud; Brigitte Bouchindhomme; Emmanuelle Leteurtre; Michael Perrais; François Pattou; Christine Do Cao
Journal:  Virchows Arch       Date:  2018-02-01       Impact factor: 4.064

8.  Detection of mutations in RET proto-oncogene codon 634 through double tandem hybridization.

Authors:  Rogelio Maldonado-Rodríguez; Mercedes Espinosa-Lara; Oscar Barrera-León; Carmen Colin-Tovar; Beatriz González-Yebra; Mauricio Salcedo-Vargas; J Carlos Santiago-Hernández; Alfonso Méndez-Tenorio; Kenneth L Beattie
Journal:  Mol Biotechnol       Date:  2003-10       Impact factor: 2.695

Review 9.  Thyroid Cancer in the Pediatric Population.

Authors:  Vera A Paulson; Erin R Rudzinski; Douglas S Hawkins
Journal:  Genes (Basel)       Date:  2019-09-18       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.